Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Raafat Bishai"'
Autor:
Rachel D. Torok, Jennifer S. Li, Prince J. Kannankeril, Andrew M. Atz, Raafat Bishai, Ellen Bolotin, Stefanie Breitenstein, Cathy Chen, Thomas Diacovo, Timothy Feltes, Patricia Furlong, Michael Hanna, Eric M. Graham, Daphne Hsu, D. Dunbar Ivy, Dianne Murphy, Lisa A. Kammerman, Gregory Kearns, John Lawrence, Brigitte Lebeaut, Danshi Li, Christoph Male, Brian McCrindle, Pierre Mugnier, Jane W. Newburger, Gail D. Pearson, Vasum Peiris, Lisa Percival, Miriam Pina, Ronald Portman, Robert Shaddy, Norman L. Stockbridge, Robert Temple, Kevin D. Hill
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/358997288c0745aea8f714749db9b506
Autor:
William V. Tamborlane, Raafat Bishai, David Geller, Naim Shehadeh, Dalia Al-Abdulrazzaq, Evelina Mánica Vazquez, Eva Karoly, Tünde Troja, Orlando Doehring, Debra Carter, John Monyak, C. David Sjöström
OBJECTIVE Approved treatments for type 2 diabetes in pediatric patients include metformin, liraglutide, and insulin. However, approximately one-half of the youth fail metformin monotherapy within 1 year, insulin therapy is associated with challenges,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864d1b4a4f5be59a8c931b24bcdc115e
https://doi.org/10.2337/figshare.19638627.v1
https://doi.org/10.2337/figshare.19638627.v1
Autor:
Éva Károly, Dalia Al-Abdulrazzaq, David M Geller, C. David Sjöström, Debra Carter, Naim Shehadeh, Orlando Doehring, Raafat Bishai, William V. Tamborlane, John Monyak
Publikováno v:
Diabetes. 70
Aim: To evaluate the efficacy and safety of once‑weekly exenatide (EQW) in youth with T2D. Methods: Participants (aged 10 to Results: Overall, 83 participants were randomized (exenatide: 59; placebo: 24); 72 completed 24-week treatment. Baseline ch
Autor:
Prince J. Kannankeril, Robert E. Shaddy, Dianne Murphy, Rachel D. Torok, Patricia Furlong, Andrew M. Atz, D. Dunbar Ivy, Danshi Li, Gail D. Pearson, Brian W. McCrindle, Ronald J. Portman, Thomas G. Diacovo, Daphne T. Hsu, Michael G. Hanna, Miriam Pina, Brigitte Lebeaut, Lisa Percival, Cathy Chen, Christoph Male, Eric M. Graham, Lisa A. Kammerman, Kevin D. Hill, Ellen Bolotin, Raafat Bishai, Pierre Mugnier, Jane W. Newburger, Jennifer S. Li, Timothy F. Feltes, John H. Lawrence, Norman Stockbridge, Robert Temple, Vasum Peiris, Stefanie Breitenstein, Gregory L. Kearns
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Children have historically been underrepresented or, indeed, omitted entirely, in drug trials, leading to a relative dearth of evidence in support of appropriate drug treatments for many pediatric diseases.[1][1], [2][2] Recent legislative initiative
Autor:
Ashley Strougo, Solange Corriol-Rohou, Angela Joubert James, Dennis Potempa, Steven J. Kovacs, Raafat Bishai, Christina Bucci-Rechtweg, Jeffrey S. Barrett, Jing Liu, Amy Cheung, Sebastian Haertter, Konstantina M. Vanevski
Publikováno v:
Clinical pharmacology and therapeutics. 103(3)
Extrapolation can be used to address challenges in pediatric drug development. This review describes how these challenges could be addressed by further evolution of quantitative frameworks (i.e., model-based/informed drug discovery and development) a
Autor:
Benjamin Bar-Oz, Guy Mareels, Gideon Koren, Johan Verspeelt, Tony Van Tittelboom, Myla E Moretti, Raafat Bishai
Publikováno v:
American Journal of Obstetrics and Gynecology. 183:617-620
Objective: This study was undertaken to determine whether itraconazole use during the first trimester of pregnancy was associated with increased risks of major malformations, spontaneous abortions, premature deliveries, and neonatal complications. St
Autor:
Raafat Bishai, Marcus Gobrial, Gideon Koren, Jacob Wolpin, Sohail Khattak, Goli Hashemi, Sylvian Baruchel, Shinya Ito, Gordana Atanackovic, Ronen Loebstein
Publikováno v:
The Journal of Clinical Pharmacology. 39:454-461
Ifosfamide is widely used in the treatment of pediatric solid tumors. Its main adverse effects are various forms of renal tubular and glomerular damage. The authors sought to determine factors that predict the risk for the development and severity of
Autor:
Stephanie S. O'Malley, Vijay A. Ramchandani, Raafat Bishai, David T. George, Cheryl L. Jones, Christopher B. Geyer, Debra Hill, David Herion, Robert R. Rawlings, Erick Singley, Markus Heilig, George Kunos, David E. Spero, Monte J. Phillips, Jacqueline Hersh
Publikováno v:
Psychopharmacology. 208(1)
There is an extensive literature showing that the CB(1) cannabinoid receptor antagonist rimonabant (SR141716) decreases alcohol consumption in animals, but little is known about its effects in human alcohol drinkers.In this study, 49 nontreatment-see
Autor:
Raafat Bishai, Gideon Koren, Kiran Chandra, Laura A. Magee, Caroline Maltepe, Yvette Navioz, Cheryl Attard, Michele Kohli, Gordana Atanackovic
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 94(1)
The symptomatology of nausea and vomiting of pregnancy (NVP) ranges from mild to very severe. The most advanced method to measure the burden of NVP, the Rhode’s scores, incorporates physical signs (length and number of episodes of nausea, number an
Publikováno v:
Pediatrics. 104:e31-e31
Background. Lidocaine–prilocaine cream (EMLA) is currently standard therapy to alleviate procedural pain in children. One of the disadvantages of lidocaine–prilocaine is the need to wait for 60 minutes for adequate skin anesthesia. Amethocaine ge